Who invested in LQ3 Pharmaceuticals?
LQ3 Pharmaceuticals's investors include Canaan, Correlation Ventures and Envisia Therapeutics.

United States · Series A startup
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow LQ3 Pharmaceuticals and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$10Mraised across 1 round since 2014, from 1 source
From a historical funding recordSEC filing: $2.0M sold, first sale Jul 2014
LQ3 Pharmaceuticals filed one raise, $2.4M in all. Filings say how much was sold and to how many investors; they never name the investors.
From the SEC filings it signed: 3 on the team.
On the board, as filediNeal FowlerSeth RudnickStephen Bloch
LQ3 Pharmaceuticals's investors include Canaan, Correlation Ventures and Envisia Therapeutics.
LQ3 Pharmaceuticals has raised $10M across 1 round since 2014.
LQ3 Pharmaceuticals's most recent round was a Series A of $10M in Sept 2014.
Its most recent round, $10M in Sept 2014, is also its largest on record.
LQ3 Pharmaceuticals's first round on record, in Sept 2014, was backed by Canaan, Correlation Ventures and Envisia Therapeutics.
LQ3 Pharmaceuticals's latest named round is a Series A, in Sept 2014.
LQ3 Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.